The effect of pegylated interferon-α on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection
Open Access
- 18 January 2006
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 44 (3) , 507-511
- https://doi.org/10.1016/j.jhep.2005.12.004
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Four years of lamivudine treatment in Chinese patients with chronic hepatitis BJournal of Gastroenterology and Hepatology, 2004
- Efficacy of alpha interferon therapy for lamivudine resistance in chronic hepatitis BInternational Journal Of Clinical Practice, 2004
- Management of YMDD mutations during lamivudine therapy in patients with chronic hepatitis BJournal of Gastroenterology and Hepatology, 2002
- Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapyThe Esophagus, 2002
- Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trialJournal of Hepatology, 2001
- Extended Lamivudine Treatment in Patients With Chronic Hepatitis B Enhances Hepatitis B E Antigen Seroconversion Rates: Results After 3 Years of TherapyHepatology, 2001
- Effects of extended lamivudine therapy in Asian patients with chronic hepatitis BGastroenterology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995